Also the Pattos options are not performance based they are going to get 15 m oppies its just that they have different exercise prices and expiry dates.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025